Autoimmune Technologies, LLC   Report issue

For profit Phase 2
Founded: New Orleans LA United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2011
NCT01313962
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now